Tech
|
Updated on 04 Nov 2025, 11:31 am
Reviewed By
Simar Singh | Whalesbook News Team
▶
OpenAI is providing a one-year free trial of its ChatGPT Go subscription for users in India, marking a major effort to expand its reach in one of its fastest-growing markets. This initiative coincides with OpenAI's first DevDay Exchange event in Bengaluru, emphasizing India's crucial role in AI development.
ChatGPT Go is OpenAI's affordable subscription tier that grants access to advanced features like GPT-5, higher message limits, image generation, data analysis, and customization tools. It bridges the gap between the free plan and ChatGPT Plus, offering enhanced capabilities.
The promotion is open to new users, existing free-tier users, and current ChatGPT Go subscribers. Users on higher-tier plans must cancel their existing subscriptions. To avail the offer, users need to add a valid payment method, such as a credit card or UPI. While a temporary Re 1 charge may apply for UPI verification, it will be refunded.
Users can redeem the offer via the ChatGPT web platform or the Google Play Store. Availability on the Apple App Store is expected next week. Existing ChatGPT Go subscribers will have their billing automatically extended by 12 months, though those subscribed via the Apple App Store will need to cancel and resubscribe once the offer is live.
Impact: This initiative is expected to significantly boost AI adoption and user engagement in India. It reinforces India's position as a key market for artificial intelligence, potentially spurring innovation among developers and businesses. The increased accessibility to advanced AI tools could have a positive, albeit indirect, impact on the Indian technology sector's growth and talent development. Rating: 7/10.
Difficult Terms: * **ChatGPT Go**: A low-cost subscription plan from OpenAI that provides access to advanced AI features and models. * **GPT-5**: OpenAI's most advanced large language model, offering enhanced capabilities in understanding and generating text. * **AI adoption**: The process of integrating Artificial Intelligence technologies into various aspects of life, business, or industry. * **DevDay Exchange**: An event organized by OpenAI for developers to engage with AI technologies and the company's offerings. * **IndiaAI Mission**: A government initiative in India designed to promote and support the development and deployment of artificial intelligence across the country. * **Billing cycle**: The recurring period over which a service is charged to a customer. * **UPI**: Unified Payments Interface, a real-time payment system in India enabling instant money transfers.
Tech
Why Pine Labs’ head believes Ebitda is a better measure of the company’s value
Tech
Bharti Airtel maintains strong run in Q2 FY26
Tech
Mobikwik Q2 Results: Net loss widens to ₹29 crore, revenue declines
Tech
Fintech Startup Zynk Bags $5 Mn To Scale Cross Border Payments
Tech
Flipkart sees 1.4X jump from emerging trade hubs during festive season
Tech
TVS Capital joins the search for AI-powered IT disruptor
Energy
Stock Radar: RIL stock showing signs of bottoming out 2-month consolidation; what should investors do?
Banking/Finance
ED’s property attachment won’t affect business operations: Reliance Group
Economy
SBI joins L&T in signaling revival of private capex
Industrial Goods/Services
Berger Paints Q2 net falls 23.5% at ₹206.38 crore
Startups/VC
Fambo eyes nationwide expansion after ₹21.55 crore Series A funding
Mutual Funds
Best Nippon India fund: Rs 10,000 SIP turns into Rs 1.45 crore; lump sum investment grows 16 times since launch
Auto
Royal Enfield to start commercial roll-out out of electric bikes from next year, says CEO
Auto
Mahindra in the driver’s seat as festive demand fuels 'double-digit' growth for FY26
Auto
SUVs toast of nation, driving PV sales growth even post GST rate cut: Hyundai
Auto
Farm leads the way in M&M’s Q2 results, auto impacted by transition in GST
Auto
SUVs eating into the market of hatchbacks, may continue to do so: Hyundai India COO
Auto
Norton unveils its Resurgence strategy at EICMA in Italy; launches four all-new Manx and Atlas models
Healthcare/Biotech
Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion
Healthcare/Biotech
Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure
Healthcare/Biotech
Metropolis Healthcare Q2 net profit rises 13% on TruHealth, specialty portfolio growth